Equal-WT
WhaleScore 2.0
?
SLATE PATH CAPITAL LP
NEW YORK NY
Investment Advisor
Hedge Fund
Slate Path Capital is based out of New York. Slate Path Capital is a hedge fund with 6 clients and discretionary assets under management (AUM) of $6,880,570,797 (Form ADV from 2024-03-29). Their last reported 13F filing for Q2 2024 included $5,253,057,754 in managed 13F securities
and a top 10 holdings concentration of 44.21%. Slate Path Capital's largest holding is Teva Pharmaceutical Industries Ltd, ADR with shares held of 20,191,184. Whalewisdom has at least 47 13F filings, 1 13D filings, 14 13G filings, and 2 Form 4 filings
Business Description
Slate Path Capital LP provides discretionary investment management and administrative services to clients. These clients are privately offered pooled investment vehicles, commonly referred to as hedge funds or private funds. Slate Path acts as an investment advisor or manager for these funds, with the terms of their relationships outlined in investment management agreements or the governing documents of the funds.
The terms of the funds are further detailed in Confidential Private Placement Memoranda or Confidential Offering Memoranda, and are only offered to investors who meet specific criteria, including being accredited investors, qualified purchasers, knowledgeable employees, or non-U.S. persons.
Investment Strategy
Slate Path aims to achieve long-term risk-adjusted capital growth through a fundamental, research-based security selection process. The Funds that invest in the Master Funds are global long short funds that primarily focus on equities but also hold significant non-equity positions. These Funds maintain both long and short positions in their portfolios.
Investment opportunities are allocated among clients based on factors such as available capital, risk-return profile alignment with client objectives, potential portfolio imbalance, client liquidity requirements, potential tax consequences, regulatory restrictions, and portfolio risk management. Slate Path reviews allocation differences to ensure fairness and equity over time.
Other Contact Information
(Subscription Required)
2024-06-30
Top Buys (13F)
| Name | % Change |
|---|---|
| DAL Delta Air Lines Inc. | 3.72% |
| CSCO Cisco Systems, Inc. | 3.51% |
| STX Seagate Technology p (CALL) | 2.93% |
| HPE Hewlett Packard Ente | 2.09% |
| GEV GE Vernova Inc. | 2.04% |
2024-06-30
Top Sells (13F)
| Name | % Change |
|---|---|
| GDX VanEck Gold Miners E | 2.62% |
| VTRS Viatris Inc | 2.56% |
| MU Micron Technology, I | 2.31% |
| ERIC Ericsson (L.M.) Tele | 1.85% |
| PRGO Perrigo Co PLC | 1.82% |
2024-06-30
13F Holdings Summary
| Name | $ Change |
|---|---|
| TEVA Teva Pharmaceutical | 6.25% |
| STX Seagate Technology p | 6.12% |
| WDC Western Digital Corp | 5.48% |
| HPE Hewlett Packard Ente | 4.96% |
| SE Sea Ltd ADR | 3.88% |
2024-06-30
13F Activity
| Market Value | $5.25b, Prior: $5.04b |
| Inflows (Outflows) as % of Total MV | (-0.8256)% |
| New Purchases | 15 stocks |
| Added To | 11 stocks |
| Sold out of | 15 stocks |
| Reduced holdings in | 13 stocks |
| Top 10 Holdings % | 44.21% |
| Turnover %[1] | 38.96% |
| Turnover Alt %[2] | 27% |
| Time Held Top 20 | 2.7 quarters |
| Time Held Top 10 | 2.1 quarters |
| Time Held All | 6.06 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2024-06-30
13F Sector Allocation Over Time
limited to past 4 quarters. Subscribe to see all available data
2024-06-30
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2024-06-30